{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -0.14, "epsForward": -3.28, "epsCurrentYear": -6.49, "priceEpsCurrentYear": -3.8135595, "sharesOutstanding": 350891008, "bookValue": 0.272, "fiftyDayAverage": 26.132, "fiftyDayAverageChange": -1.382, "fiftyDayAverageChangePercent": -0.05288535, "twoHundredDayAverage": 39.844685, "twoHundredDayAverageChange": -15.094685, "twoHundredDayAverageChangePercent": -0.3788381, "marketCap": 86845520, "forwardPE": -0.07545731, "priceToBook": 90.992645, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Creo Medical Limited", "nameChangeDate": "2023-05-12", "averageAnalystRating": "1.5 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "currency": "GBp", "financialCurrency": "GBP", "regularMarketOpen": 24.8, "averageDailyVolume3Month": 902548, "averageDailyVolume10Day": 286604, "fiftyTwoWeekLowChange": 6.4132996, "fiftyTwoWeekLowChangePercent": 0.3497521, "fiftyTwoWeekRange": "18.3367 - 104.0", "fiftyTwoWeekHighChange": -79.25, "fiftyTwoWeekHighChangePercent": -0.7620192, "fiftyTwoWeekLow": 18.3367, "fiftyTwoWeekHigh": 104.0, "earningsTimestamp": 1682488810, "earningsTimestampStart": 1682488810, "earningsTimestampEnd": 1682488810, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1481270400000, "priceHint": 2, "marketState": "CLOSED", "regularMarketChange": -0.25, "regularMarketTime": 1683905701, "regularMarketDayHigh": 25.0, "regularMarketDayRange": "24.36 - 25.0", "regularMarketDayLow": 24.36, "regularMarketVolume": 73558, "regularMarketPreviousClose": 25.0, "bid": 24.5, "ask": 25.5, "bidSize": 0, "askSize": 0, "fullExchangeName": "LSE", "regularMarketChangePercent": -1.0, "regularMarketPrice": 24.75, "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "esgPopulated": false, "exchange": "LSE", "shortName": "CREO MEDICAL GROUP PLC ORD GBP0", "longName": "Creo Medical Group PLC", "messageBoardId": "finmb_206505629", "market": "gb_market", "symbol": "CREO.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Creo House", "address2": "Unit 2, Beaufort Park Beaufort Park Way", "city": "Chepstow", "zip": "NP16 5UH", "country": "United Kingdom", "phone": "44 1291 606005", "website": "https://creomedical.com", "industry": "Medical Devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Creo Medical Group PLC, through its subsidiaries, engages in the research and development, manufacture, and sale of medical devices and instruments in the United Kingdom. It is developing Croma, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; MicroBlate Fine, a microwave needle ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highly perfused tissues; and endotherapy accessories. Creo Medical Group PLC was founded in 2003 and is based in Chepstow, United Kingdom.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Craig Jonathan Gulliford", "age": 51, "title": "CEO & Exec. Director", "yearBorn": 1971, "fiscalYear": 2021, "totalPay": {"raw": 621715, "fmt": "621.72k", "longFmt": "621,715"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 3157179, "fmt": "3.16M", "longFmt": "3,157,179"}}, {"maxAge": 1, "name": "Prof. Christopher Paul Hancock", "age": 54, "title": "Founder, CTO & Exec. Director", "yearBorn": 1968, "fiscalYear": 2021, "totalPay": {"raw": 474156, "fmt": "474.16k", "longFmt": "474,156"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1550587, "fmt": "1.55M", "longFmt": "1,550,587"}}, {"maxAge": 1, "name": "Mr. Richard John Rees ACA", "age": 45, "title": "CFO, Company Sec. & Exec. Director", "yearBorn": 1977, "fiscalYear": 2021, "totalPay": {"raw": 472351, "fmt": "472.35k", "longFmt": "472,351"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1288231, "fmt": "1.29M", "longFmt": "1,288,231"}}, {"maxAge": 1, "name": "Mr. David Gerard Woods", "age": 56, "title": "Chief Commercial Officer & Exec. Director", "yearBorn": 1966, "fiscalYear": 2021, "totalPay": {"raw": 555860, "fmt": "555.86k", "longFmt": "555,860"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Phil  Hales", "title": "Sales & Marketing Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}